Dr Christophe Portal has been appointed as Chief Scientific Officer.

Christophe has 15 years of industrial experience in the research and development of peptide and peptide like molecules for imaging and therapy. He started his career working for a biotechnology company developing optical imaging agents for oncology imaging. He subsequently worked for the University of Edinburgh as Chemistry Group Leader and then joined a spinoff of the University dealing with novel drug discovery screening techniques. Christophe holds a Master of Science degree in Biooorganic Chemistry from Marseilles University and a PhD in Chemical Biology from the University of Edinburgh.